Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
García-Gutiérrez, María S.
Navarrete, Francisco
Gasparyan, Ani
Austrich-Olivares, Amaya
Sala, Francisco
and
Manzanares, Jorge
2020.
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
Biomolecules,
Vol. 10,
Issue. 11,
p.
1575.
Davies, Cathy
Wilson, Robin
Appiah-Kusi, Elizabeth
Blest-Hopley, Grace
Brammer, Michael
Perez, Jesus
Murray, Robin M.
Allen, Paul
Bossong, Matthijs G.
McGuire, Philip
and
Bhattacharyya, Sagnik
2020.
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis.
Translational Psychiatry,
Vol. 10,
Issue. 1,
Colizzi, Marco
Ruggeri, Mirella
and
Bhattacharyya, Sagnik
2020.
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition.
Frontiers in Psychology,
Vol. 11,
Issue. ,
Colizzi, Marco
and
Bhattacharyya, Sagnik
2020.
Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior.
Brain Sciences,
Vol. 10,
Issue. 11,
p.
834.
Sadaka, Aymen H.
Ozuna, Ana G.
Ortiz, Richard J.
Kulkarni, Praveen
Johnson, Clare T.
Bradshaw, Heather B.
Cushing, Bruce S.
Li, Ai-Ling
Hohmann, Andrea G.
and
Ferris, Craig F.
2021.
Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice.
Journal of Translational Medicine,
Vol. 19,
Issue. 1,
Ahmed, Saeed
Roth, Robert M.
Stanciu, Corneliu N.
and
Brunette, Mary F.
2021.
The Impact of THC and CBD in Schizophrenia: A Systematic Review.
Frontiers in Psychiatry,
Vol. 12,
Issue. ,
Gunasekera, Brandon
Davies, Cathy
Martin-Santos, Rocio
and
Bhattacharyya, Sagnik
2021.
The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol.
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging,
Vol. 6,
Issue. 6,
p.
636.
Pisani, Sara
McGoohan, Katie
Velayudhan, Latha
and
Bhattacharyya, Sagnik
2021.
Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies.
Drugs & Aging,
Vol. 38,
Issue. 10,
p.
887.
Hotz, Janine
Fehlmann, Bernhard
Papassotiropoulos, Andreas
de Quervain, Dominique JF.
and
Schicktanz, Nathalie S.
2021.
Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial.
Journal of Psychiatric Research,
Vol. 143,
Issue. ,
p.
327.
Pretzsch, Charlotte M.
Floris, Dorothea L.
Voinescu, Bogdan
Elsahib, Malka
Mendez, Maria A.
Wichers, Robert
Ajram, Laura
Ivin, Glynis
Heasman, Martin
Pretzsch, Elise
Williams, Steven
Murphy, Declan G. M.
Daly, Eileen
and
McAlonan, Gráinne M.
2021.
Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin.
Molecular Autism,
Vol. 12,
Issue. 1,
Fliegel, Danielle K.
and
Lichenstein, Sarah D.
2022.
Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety.
Psychiatry Research Communications,
Vol. 2,
Issue. 4,
p.
100074.
Tang, Yuni
Tonkovich, Kolbi L.
and
Rudisill, Toni Marie
2022.
The Effectiveness and Safety of Cannabidiol in Non-seizure-related Indications: A Systematic Review of Published Randomized Clinical Trials.
Pharmaceutical Medicine,
Vol. 36,
Issue. 6,
p.
353.
Chesney, Edward
Oliver, Dominic
and
McGuire, Philip
2022.
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis.
Psychopharmacology,
Vol. 239,
Issue. 5,
p.
1179.
Narayan, Andrea J.
Downey, Luke A.
Manning, Brooke
and
Hayley, Amie C.
2022.
Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance.
Neuroscience & Biobehavioral Reviews,
Vol. 143,
Issue. ,
p.
104941.
Wall, Matthew B
Freeman, Tom P
Hindocha, Chandni
Demetriou, Lysia
Ertl, Natalie
Freeman, Abigail M
Jones, Augustus PM
Lawn, Will
Pope, Rebecca
Mokrysz, Claire
Solomons, Daniel
Statton, Ben
Walker, Hannah R
Yamamori, Yumeya
Yang, Zixu
Yim, Jocelyn LL
Nutt, David J
Howes, Oliver D
Curran, H Valerie
and
Bloomfield, Michael AP
2022.
Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain.
Journal of Psychopharmacology,
Vol. 36,
Issue. 6,
p.
732.
Sainz-Cort, Alberto
Jimenez-Garrido, Daniel
Muñoz-Marron, Elena
Viejo-Sobera, Raquel
Heeroma, Joost
and
Bouso, Jose Carlos
2022.
The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study.
Cannabis and Cannabinoid Research,
Baratta, F.
Pignata, I.
Ravetto Enri, L.
and
Brusa, P.
2022.
Cannabis for Medical Use: Analysis of Recent Clinical Trials in View of Current Legislation.
Frontiers in Pharmacology,
Vol. 13,
Issue. ,
Bilbao, Ainhoa
and
Spanagel, Rainer
2022.
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
BMC Medicine,
Vol. 20,
Issue. 1,
Gunasekera, Brandon
Diederen, Kelly
and
Bhattacharyya, Sagnik
2022.
Cannabinoids, reward processing, and psychosis.
Psychopharmacology,
Vol. 239,
Issue. 5,
p.
1157.
Davies, Cathy
Appiah-Kusi, Elizabeth
Wilson, Robin
Blest-Hopley, Grace
Bossong, Matthijs G.
Valmaggia, Lucia
Brammer, Michael
Perez, Jesus
Allen, Paul
Murray, Robin M.
McGuire, Philip
and
Bhattacharyya, Sagnik
2022.
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 272,
Issue. 3,
p.
461.